SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-21-002407
Filing Date
2021-10-12
Accepted
2021-10-12 08:36:11
Documents
2
Period of Report
2021-10-07

Document Format Files

Seq Description Document Type Size
1 form312566003_10112021.html 3  
1 form312566003_10112021.xml 3 1593
2 ex24form312566003_10112021.htm EX-24 6511
  Complete submission text file 0000921895-21-002407.txt   9660
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVE. SUNNYVALE CA 94085
Business Address
Clark Kenneth A (Reporting) CIK: 0001561736 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 211317093

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations